This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma company that went public through a reverse merger of Aesther Healthcare Acquisition Corp. – a Special Purpose Acquisition Company (“SPAC”) formed to acquire a company seeking to go public. SPACs gained popularity in 2020/2021 as a faster/cheaper route for private companies to go public.
This report is currently available to premium subscribers – Free subscribers will gain access on Mar 22nd, 2022 Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay
Visit Ocean Biomedical, Inc. page for more research, discussion boards and to like, and share.
